Symbiosis Animal Health Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.40 M
- Revenue Growth 44.95%
- Profit Growth 140.86%
- Ebitda 140.86%
- Net Worth 29.33%
- Total Assets 115.99%
About Symbiosis Animal Health
Symbiosis Animal Health Private Limited (SAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 September 2014 and has a history of Ten years and four months. Its registered office is in Morena, Madhya Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.40 M.
Kanhaiya and Pawan Tyagi serve as directors at the Company.
Company Details
- Location
Morena, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U15331MP2014PTC033231
- Company No.
033231
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Symbiosis Animal Health?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanhaiya  | Director | 22-Sep-2014 | Current |
| Pawan Tyagi | Director | 22-Sep-2014 | Current |
Financial Performance of Symbiosis Animal Health.
Symbiosis Animal Health Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.95% increase. The company also saw a substantial improvement in profitability, with a 140.86% increase in profit. The company's net worth Soared by an impressive increase of 29.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symbiosis Animal Health?
In 2021, Symbiosis Animal Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pjb Nutraceutical Hub Private LimitedPawan Tyagi is a mutual person
Charges (Loans)
₹9.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.94 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2023 | Others | ₹9.40 M | Open |
How Many Employees Work at Symbiosis Animal Health?
Symbiosis Animal Health has a workforce of 24 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbiosis Animal Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiosis Animal Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.